Companies

Pyxis Oncology, Inc. (PYXS) SEC filings

CIK 0001782223 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)13.9 M
Net income (USD)-79.6 M-73.8 M-120.7 M
Diluted EPS (USD/shares)-1.28-1.85-3.65

Latest filings

FiledFormDescriptionPeriod
2026-10-09PRE 14APRE 14A2026-10-09
2026-10-09SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-094/A4/A2026-10-01
2026-10-05SCHEDULE 13GSCHEDULE 13G
2026-10-02442026-10-01
2026-10-02SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-018-KFORM 8-K items 1.01,8.01,9.012026-09-29
2026-10-01424B5FORM 424B5
2026-09-29424B5FORM 424B5
2026-09-29424B5FORM 424B5
2026-09-098-K8-K items 7.01,8.01,9.012026-09-09
2026-09-08442026-09-04
2026-09-088-K8-K items 5.02,7.01,9.012026-09-03
2026-08-28424B2424B2
2026-08-27EFFECTEFFECT items ,,
2026-08-20442026-08-20
2026-08-20S-3S-3
2026-08-14442026-08-12
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.022026-08-13
2026-07-10332026-06-30
2026-07-10SCHEDULE 13GSCHEDULE 13G
2026-07-02442026-06-30
2026-07-028-K8-K items 1.01,3.02,7.012026-06-30
2026-07-02SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 102, 8-K 56, 3 21, 144 19, 10-Q 15, SC 13G/A 11, 425 9, SCHEDULE 13G/A 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=PYXS (0.002 USD), /gw/filings/filings?ticker=PYXS&form=8-K, /gw/filings/facts?ticker=PYXS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange